1) human gastric carcinoma (BGC) cancer cell lines
BGC胃癌细胞株
2) Human gastric carcinoma cell line BGC
人胃癌细胞株BGC
1.
Inhibitory Effects of 40 Coumarins Compounds Against Growth of Human Gastric Carcinoma Cell Line BGC and Human Hepatic Carcinoma Cell Line BEL-7402 in Vitro;
40种香豆素类化合物对人胃癌细胞株BGC和人肝癌细胞株BEL-7402细胞生长抑制活性的筛选
2.
were studied for their antitumor activity in vitro by determining the inhibitory percentage against growth of human nasopharyngeal carcinoma cell line KB,human leukemia cell line HL-60,human gastric carcinoma cell line BGC and human hepatic carcinoma cell line BEL-7402.
方法应用人鼻咽癌细胞株KB、人白血病细胞株HL-60、人胃癌细胞株BGC和人肝癌细胞株BEL-7402筛选6种马钱子生物碱类成分对其生长的抑制作用。
3) gastric BGC cells
人胃癌BGC细胞株
4) grastic cancer cell line BGC-823
胃癌细胞株BGC-823
1.
Objective:To Investigate the inhibitory effect and mechanisis of combined treatment of the gastrin receptor antagonist proglumide and the selective COX-2 inhibitor celecoxib on cultured human grastic cancer cell line BGC-823 in vitro.
目的:探讨胃泌素受体拮抗剂丙谷胺和选择性还氧合酶-2抑制剂塞来昔布对体外培养的人胃癌细胞株BGC-823增殖抑制作用及其机制。
5) human gastric carcinoma cells BGC-823
人胃癌细胞BGC-823
1.
The mechanism of apoptosis in human gastric carcinoma cells BGC-823 induced with recombinant plasmid comprised Hemagglutinin-neuraminidase(HN) gene from newcastle disease virus;
新城疫病毒HN基因重组体对人胃癌细胞BGC-823凋亡作用机制研究
6) Human gastric BGC-823 cell
人胃癌BGC-823细胞
1.
Incubation of human gastric BGC-823 cells with different concentration (15 μ g/ml, 30 μ g/ml and 45 μ g/ml) of EPA and DHA for 48h, then PKC β II were detected by flow cytometry,immuno cytochemistry and Western blot.
方法:将人胃癌BGC-823细胞分对照组、EPA药物组和DHA 药物组,EPA组和DHA组按15 μ g／ml、30 μ g／ml、45μ g／ml加药,肿瘤细胞培养48小时后,用流式细胞仪测定胃癌细胞PKC β II蛋白含量(鼠抗人PKC βⅡ抗体,1:50),以荧光指数(Flurorescene Index,FI)表示蛋白相对含量:FI= {样品蛋白表达的平均荧光强度／正常对照样品平均荧光强度} ×100％。
2.
Incubation of human gastric BGC-823 cells with different concentration (15 μ g/ml, 30 μ g/ml and 45 μ g/ml) of EPA and DHA for 48h,then NF- κ B p65 were detected by immuno cytochemistry, Western blot and TR-PCR.
方法:将人胃癌BGC-823细胞分对照组、 EPA药物组和DHA药物组,EPA组和DHA组按15 μg／ml、 30 μ g／ml和45 μg／ml药物浓度加药,肿瘤细胞加药继续培养48小时后,用SP-9000免疫细胞化学检测胃癌细胞NF- κ B p65蛋白分布(鼠抗人NF κ B p65单克隆抗体1:100), DAB显色,观察。
3.
When human gastric BGC-823 cells were treated by 15 μg/mL,30 μg/mL and 45 μg/mL of EPA and DHA after 48 hours, the techniques were used as follows: arachidonic acid (AA), EPA and DH.
本研究通过观察ω-3多不饱和脂肪酸制剂二十碳五烯酸 (cis-5,8,11,14,17-eicosapentaenoic aicd,EPA)和二十二碳六烯酸(cis-4,7,10,13,16,19-docosahexaenoic acid, DHA)对人胃癌BGC-823细胞膜ω-6多不饱和脂肪酸物质花生四烯酸(arachidonic acid,AA)和细胞内前列腺素E2 (PGE2)的影响,探讨ω-3多不饱和脂肪酸对人胃癌BGC- 823细胞的抑制作用机制。
补充资料：细胞株
分子式：
CAS号：
性质：用单细胞分离培养法或克隆形成法从原代培养或从细胞系所选出的细胞群，称细胞株。一个细胞株应具有特定的生物学性质和标记并持续存在。
CAS号：
性质：用单细胞分离培养法或克隆形成法从原代培养或从细胞系所选出的细胞群，称细胞株。一个细胞株应具有特定的生物学性质和标记并持续存在。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条